Clinical trial NCT02862717 - References

End Stage Renal Disease — Cost Utility Analysis of HD and CAPD in Ministry of Health Dialysis Centres, Malaysia

Citation(s)

•   EBPG (European Expert Group on Renal Transplantation); European Renal Association (ERA-EDTA); European Society for Organ Transplantation (ESOT)
  European Best Practice Guidelines for Renal Transplantation (part 1). Nephrol Dial Transplant. 2000;15 Suppl 7:1-85.
•   Fresenius Medical Care
  2013. ESRD patients in 2013, "A Global Perspective". Retrieved from http://www.vision-fmc.com/files/ESRD_Patients_in_2013.pdf
•   Goh, B
  L. and Ong, L.M (Eds).2014. 22nd Report of the Malaysian Dialysis and Transplant Registry. National Renal Registry.
•   Green, F
  and Ryan, C. 2009. Health care expenditure on chronic kidney disease in Australia, 2009 Cat. no. PHE 117. Canberra: AIHW. Retrieved from http://www.aihw.gov.au/publication-detail/?id=6442468279
•   Hooi LS, Lim TO, Goh A, Wong HS, Tan CC, Ahmad G, Morad Z
  Economic evaluation of centre haemodialysis and continuous ambulatory peritoneal dialysis in Ministry of Health hospitals, Malaysia. Nephrology (Carlton). 2005 Feb;10(1):25-32.
•   Institute for Health Metrics and Evaluation (IHME)
  2013. Malaysia Global Burden of Disease Study 2010 (GBD 2010) Results 1990-2010. Seattle, United States.
•   Kerr M, Bray B, Medcalf J, O'Donoghue DJ, Matthews B
  Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol Dial Transplant. 2012 Oct;27 Suppl 3:iii73-80. doi: 10.1093/ndt/gfs269. Epub 2012 Aug 5.
•   Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, Lameire N, Eknoyan G
  Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007 Aug;72(3):247-59. Epub 2007 Jun 13.
•   Lim TO, Goh A, Lim YN, Mohamad Zaher ZM, Suleiman AB
  How public and private reforms dramatically improved access to dialysis therapy in Malaysia. Health Aff (Millwood). 2010 Dec;29(12):2214-22. doi: 10.1377/hlthaff.2009.0135.
•   Malaysia National Health Account (MNHA), Planning Division
  2013. Health Expenditure Report 1997-2012. Ministry of Health Malaysia.
•   Meier-Kriesche HU, Schold JD, Srinivas TR, Reed A, Kaplan B
  Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease. Am J Transplant. 2004 Oct;4(10):1662-8.
•   Sennfält K, Magnusson M, Carlsson P
  Comparison of hemodialysis and peritoneal dialysis--a cost-utility analysis. Perit Dial Int. 2002 Jan-Feb;22(1):39-47.
•   United States Renal Data System (USRD)
  2015. Chapter 11: Medicare expenditures forperson with ESRD. Retrieved from http://www.usrds.org/2015/view/v2_11.aspx
•   Winkelmayer WC, Glynn RJ, Mittleman MA, Levin R, Pliskin JS, Avorn J
  Comparing mortality of elderly patients on hemodialysis versus peritoneal dialysis: a propensity score approach. J Am Soc Nephrol. 2002 Sep;13(9):2353-62.
•   World Health Organization, Global Burden of Disease
  2014. Regional Estimates for 2000-2012, DALY Estimates. Retrieved from http://www.who.int/healthinfo/global_burden_disease/estimates/en/index2.html
•   Yusof FA, Goh A, Azmi S
  Estimating an EQ-5D value set for Malaysia using time trade-off and visual analogue scale methods. Value Health. 2012 Jan-Feb;15(1 Suppl):S85-90. doi: 10.1016/j.jval.2011.11.024.

Cost Utility Analysis of End Stage Renal Disease Treatment in Ministry of Health Dialysis Centres, Malaysia: Haemodialysis Versus Continuous Ambulatory Peritoneal Dialysis

Details for clinical trial NCT02862717